Literature DB >> 30892340

Rhodamine-modified fluorescent half-sandwich iridium and ruthenium complexes: potential application as bioimaging and anticancer agents.

Wenli Ma1, Lihua Guo, Zhenzhen Tian, Shumiao Zhang, Xiangdong He, JuanJuan Li, Yuliang Yang, Zhe Liu.   

Abstract

Most half-sandwich metal anticancer complexes are non-fluorescent, which results in an uncertain mechanism of action (MoA). We designed and synthesized eight fluorescent half-sandwich iridium (Ir) and ruthenium (Ru) complexes by introducing rhodamine derivatives into the N^N-chelating ligand. These complexes have features of bio-imaging and anticancer agents and may merit future development as novel anticancer agents.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30892340     DOI: 10.1039/c9dt00999j

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  4 in total

1.  Lysosomal Targeted Cyclometallic Iridium(Ⅲ) Salicylaldehyde-Coumarin Schiff Base Complexes and Anticancer Application.

Authors:  Ruixi Xu; Yuting Wu; Zhe Liu; Jinfeng Liu; Xicheng Liu
Journal:  Front Chem       Date:  2022-05-10       Impact factor: 5.545

2.  The effect of Rhodamine B on the cerebellum and brainstem tissue of Rattus norvegicus.

Authors:  Dewi Ratna Sulistina; Santi Martini
Journal:  J Public Health Res       Date:  2020-07-02

3.  Experimental and DFT studies of sulfadiazine 'piano-stool' Ru(ii) and Rh(iii) complexes.

Authors:  Ahmed M Mansour; Krzysztof Radacki
Journal:  RSC Adv       Date:  2020-03-12       Impact factor: 4.036

Review 4.  Photoactive and Luminescent Transition Metal Complexes as Anticancer Agents: A Guiding Light in the Search for New and Improved Cancer Treatments.

Authors:  Brondwyn S McGhie; Janice R Aldrich-Wright
Journal:  Biomedicines       Date:  2022-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.